Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points

Institution(s): 
Harvard University
Approx. Sample Size to be Sequenced: 
2400 (ph3)

Project:

Disease/Phenotype: 

COPD

PI: 
Edwin Silverman
Starting Phase: 
Phase 3
Phases Involved: 
3
Short Name: 
ECLIPSE
Sequencing Center(s) Phase 3: 
McDonnell Genome Institute
Type of Sequencing: 
WGS
Sequencing External Funding: 
TOPMed Accession #: